DE69534180D1 - Promotor der tie rezeptor protein kinase - Google Patents

Promotor der tie rezeptor protein kinase

Info

Publication number
DE69534180D1
DE69534180D1 DE69534180T DE69534180T DE69534180D1 DE 69534180 D1 DE69534180 D1 DE 69534180D1 DE 69534180 T DE69534180 T DE 69534180T DE 69534180 T DE69534180 T DE 69534180T DE 69534180 D1 DE69534180 D1 DE 69534180D1
Authority
DE
Germany
Prior art keywords
promoter
protein kinase
receptor protein
tie receptor
tie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534180T
Other languages
English (en)
Other versions
DE69534180T2 (de
Inventor
Kari Alitalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Application granted granted Critical
Publication of DE69534180D1 publication Critical patent/DE69534180D1/de
Publication of DE69534180T2 publication Critical patent/DE69534180T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69534180T 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase Expired - Fee Related DE69534180T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31071794A 1994-09-22 1994-09-22
US310717 1994-09-22
PCT/FI1995/000520 WO1996009381A1 (en) 1994-09-22 1995-09-22 Promoter for the receptor tyrosine kinase, tie

Publications (2)

Publication Number Publication Date
DE69534180D1 true DE69534180D1 (de) 2005-06-02
DE69534180T2 DE69534180T2 (de) 2006-03-02

Family

ID=23203808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534180T Expired - Fee Related DE69534180T2 (de) 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase

Country Status (8)

Country Link
US (1) US5877020A (de)
EP (1) EP0783572B1 (de)
JP (1) JPH10506011A (de)
AT (1) ATE294236T1 (de)
AU (1) AU701568B2 (de)
DE (1) DE69534180T2 (de)
NO (1) NO971341L (de)
WO (1) WO1996009381A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756570B1 (fr) * 1996-12-03 2002-09-27 Commissariat Energie Atomique Promoteur de la ve-cadherine et ses utilisations
US5972338A (en) 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6350450B1 (en) 1997-09-19 2002-02-26 Genentech, Inc. TIE ligand homologue antibody
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US6030831A (en) 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
US6130207A (en) * 1997-11-05 2000-10-10 South Alabama Medical Science Foundation Cell-specific molecule and method for importing DNA into a nucleus
AU2001244509A1 (en) * 2000-03-30 2001-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
EP1341771A2 (de) * 2000-11-29 2003-09-10 Glaxo Group Limited Benzimidazolderivate und ihre verwendung als tie-2 und/oder vegfr-2 hemmer
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
US7951819B2 (en) 2006-04-26 2011-05-31 Cancer Research Technology Limited Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
AU2008307643B9 (en) 2007-09-28 2014-04-17 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
BRPI0821227A2 (pt) 2007-12-19 2015-06-16 Cancer Rec Tech Ltd Composto, composição farmacêutica, método para preparar a mesma, uso de um composto, método para tratar uma doença ou distúrbio, para inibir função de raf e para inibir proliferação celular, inibir progressão do ciclo celular, promover apoptose, ou uma combinação de um ou mais dos mesmos
GB0807609D0 (en) * 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
DK2531502T3 (da) 2010-02-01 2014-05-19 Cancer Rec Tech Ltd 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea og associerede forbindelser og ders anvendelse i terapi
WO2014125291A1 (en) 2013-02-14 2014-08-21 Ucl Business Plc Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940703857A (ko) * 1992-01-09 1994-12-12 티모 에스코 타이, 새로운 내피 세포 수용체 티로신 키나제(tie, a novel endothelial cell receptor tyrosine kinase)
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element

Also Published As

Publication number Publication date
JPH10506011A (ja) 1998-06-16
ATE294236T1 (de) 2005-05-15
EP0783572B1 (de) 2005-04-27
AU701568B2 (en) 1999-02-04
DE69534180T2 (de) 2006-03-02
AU3474895A (en) 1996-04-09
WO1996009381A1 (en) 1996-03-28
EP0783572A1 (de) 1997-07-16
NO971341D0 (no) 1997-03-21
NO971341L (no) 1997-05-14
US5877020A (en) 1999-03-02

Similar Documents

Publication Publication Date Title
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
DE69434538D1 (de) Vaskularer endothelialer wachstumsfaktor 2
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69837996D1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE68929043T2 (de) Für androgen-rezeptor-protein kodierende dna
DE69836131D1 (de) Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
DE69726741D1 (de) Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
ATE303439T1 (de) Intrazelluläre isoform von interleukin-1 rezeptor antagonist
BR9908096A (pt) Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
BR0012704A (pt) Anticorpos antitumor, proteìnas e usos dos mesmos
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
ATE362531T1 (de) Interne ribosom eintrittstelle (ires), vektor der diesen enthaltet und dessen therapeutische verwendung
IT1299201B1 (it) Fibroblasti modificati geneticamente e loro uso
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee